Proteomics

Dataset Information

0

DYRK1A, a potential therapeutic target for head and neck squamous cell carcinoma


ABSTRACT: To identify the activated tyrosine kinase signaling pathways in HNSCC, we carried out phosphotyrosine profiling using a panel of HNSCC cell lines compared to a normal oral keratinocyte. A total of 61 unique phosphosites were identified across these cell lines. Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A (DYRK1A) was one of the kinases hyperphosphorylated at Y321 in all the HNSCC cell lines compared to the normal oral cell line OKF6/TERT1. Inhibition of DYRK1A using its specific siRNA and inhibitor resulted in a decrease in the invasion and colony formation ability of the HNSCC cell lines. Further, the treatment of mice bearing HNSCC xenograft tumors with DYRK1A inhibitor (harmine) showed regression of tumor growth. Our results demonstrate that DYRK1A could be a novel therapeutic target in HNSCC.

INSTRUMENT(S): LTQ Orbitrap Velos

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Head And Neck Squamous Cell Carcinoma Cell Line

DISEASE(S): Head And Neck Squamous Cell Carcinoma

SUBMITTER: Akhilesh Pandey  

LAB HEAD: Akhilesh Pandey

PROVIDER: PXD002132 | Pride | 2018-10-24

REPOSITORIES: pride

Dataset's files

Source:
Action DRS
HNSCC_TMT_pY1000_01.msf Msf
HNSCC_TMT_pY1000_01.pep.xml Pepxml
HNSCC_TMT_pY1000_01.prot.xml Xml
HNSCC_TMT_pY1000_01.raw Raw
Items per page:
1 - 4 of 4
altmetric image

Publications


Despite advances in clinical management, 5-year survival rate in patients with late-stage head and neck squamous cell carcinoma (HNSCC) has not improved significantly over the past decade. Targeted therapies have emerged as one of the most promising approaches to treat several malignancies. Though tyrosine phosphorylation accounts for a minority of total phosphorylation, it is critical for activation of signaling pathways and plays a significant role in driving cancers. To identify activated tyr  ...[more]

Similar Datasets

2018-10-24 | PXD001862 | Pride
2018-09-19 | PXD009241 | Pride
2019-12-18 | PXD007785 | Pride
2022-10-13 | PXD007769 | Pride
2018-10-24 | PXD002097 | Pride
2024-04-09 | MSV000094507 | MassIVE
2014-10-07 | GSE62061 | GEO
2018-10-24 | PXD001460 | Pride
2016-12-14 | PXD001554 | Pride
2013-05-03 | E-GEOD-39305 | biostudies-arrayexpress